相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Healthcare Resource Utilization for Oral Anticoagulant Reversal Therapies in Non-Valvular Atrial Fibrillation/Venous Thromboembolism Patients
Alex C. Spyropoulos et al.
CARDIOLOGY RESEARCH (2022)
Direct Oral Anticoagulant Use: A Practical Guide to Common Clinical Challenges
Ashley Chen et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)
A New Option for Reversing the Anticoagulant Effect of Factor Xa Inhibitors: Andexanet Alfa (ANDEXXA)
Kelly C. Rogers et al.
AMERICAN JOURNAL OF MEDICINE (2019)
Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors
S. J. Connolly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Variation in the Use of Warfarin and Direct Oral Anticoagulants in Atrial Fibrillation and Associated Cost Implications
Benjamin A. Rodwin et al.
AMERICAN JOURNAL OF MEDICINE (2019)
Comparative Stroke, Bleeding, and Mortality Risks in Older Medicare Patients Treated with Oral Anticoagulants for Nonvalvular Atrial Fibrillation
David J. Graham et al.
AMERICAN JOURNAL OF MEDICINE (2019)
Trends and Variation in Oral Anticoagulant Choice in Patients with Atrial Fibrillation, 2010-2017
Junya Zhu et al.
PHARMACOTHERAPY (2018)
Andexanet alfa in the treatment of acute major bleeding related to apixaban and rivaroxaban: a profile of its use in the USA
Young-A Heo
DRUGS & THERAPY PERSPECTIVES (2018)
Idarucizumab for Dabigatran Reversal - Full Cohort Analysis
Charles V. Pollack et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Intracranial hemorrhage in patients with atrial fibrillation receiving anticoagulation therapy
Renato D. Lopes et al.
BLOOD (2017)
A specific antidote for dabigatran: functional and structural characterization
Felix Schiele et al.
BLOOD (2013)
Antithrombotic drugs and risk of hemorrhagic stroke in the general population
Luis A. Garcia-Rodriguez et al.
NEUROLOGY (2013)
Use of the CHA2DS2-VASc and HAS-BLED Scores to Aid Decision Making for Thromboprophylaxis in Nonvalvular Atrial Fibrillation
Deirdre A. Lane et al.
CIRCULATION (2012)
An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies
Peter C. Austin
MULTIVARIATE BEHAVIORAL RESEARCH (2011)
Apixaban in Patients with Atrial Fibrillation
Stuart J. Connolly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation The Euro Head Survey
Ron Pisters et al.
CHEST (2010)
Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach The Euro Heart Survey on Atrial Fibrillation
Gregory Y. H. Lip et al.
CHEST (2010)
The Relative Ability of Different Propensity Score Methods to Balance Measured Covariates Between Treated and Untreated Subjects in Observational Studies
Peter C. Austin
MEDICAL DECISION MAKING (2009)
Dabigatran versus Warfarin in Patients with Atrial Fibrillation.
Stuart J. Connolly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Stratification and weighting via the propensity score in estimation of causal treatment effects: a comparative study
JK Lunceford et al.
STATISTICS IN MEDICINE (2004)
分享论文
